BRIEF-Sarepta Therapeutics jumps in premarket after eteplirsen drug trial results

NEW YORK Wed Oct 3, 2012 7:55am EDT

NEW YORK Oct 3 (Reuters) - Sarepta Therapeutics Inc : * Jumps 129.2 percent to $34.35 premarket after Duchenne Muscular Dystrophy drug eteplirsen trial results

FILED UNDER:
A couple walks along the rough surf during sunset at Oahu's North Shore, December 26, 2013. REUTERS/Kevin Lamarque

Find your dream retirement town

Florida? Hawaii? Reuters has teamed up with Zillow to give you the power to customize a list of your best places to retire.  Video | Full Article